| HOME >> BIOLOGY >> TECHNOLOGY |
Deferred transaction costs(1) - 473
-------------------------------------------------------------------------
Total assets $14,281 $19,581
-------------------------------------------------------------------------
-------------------------------------------------------------------------
Liabilities and Shareholders' Equity
Accounts payable and accrued liabilities $2,161 $1,958
-------------------------------------------------------------------------
Total current liabilities $2,161 $1,958
Convertible royalty participation units(1) 5,219 4,847
Preferred shares - 115
-------------------------------------------------------------------------
Total liabilities $7,380 $6,920
-------------------------------------------------------------------------
Shareholders' equity
Common shares $125,156 $124,994
Equity portion of convertible royalty
participation units 4,554 4,554
Contributed surplus 8,005 7,830
Deficit (130,814) (124,717)
-------------------------------------------------------------------------
Total shareholders' equity $6,901 $12,661
-------------------------------------------------------------------------
Total liabilities and shareholders' equity $14,281 $19,581
-------------------------------------------------------------------------
-------------------------------------------------------------------------
(1) As of May 1, 2007 pursuant to the adoption of n
'/>"/>
| SOURCE MIGENIX Inc. Copyright©2007 PR Newswire. All rights reserved |